Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 32 citing Go: Statin and ß-blocker therapy and the initial presentation of coronary heart disease. (0.08 sec) 

Statins and the primary prevention of cardiovascular events


M Clearfield - Current atherosclerosis reports, 2006 - Springer
Cardiovascular disease remains the leading cause of death in both men and women
in the United States. Treating elevated low-density lipoprotein (LDL) choles-
terol has been shown to be very effective in reducing the rate of coronary ...
Cited by 21 - Related articles - BL Direct - All 4 versions

Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary …


MA Hlatky, T Quertermous, DB Boothroyd, JR … - American Heart Journal, 2007 - Elsevier
The 909 patients with acute MI were significantly more likely than the 466
patients with stable angina to be male, current smokers, and hypertensive, and
less likely to be taking β-blockers or statins. Three polymorphisms in ...
Cited by 20 - Related articles - All 26 versions

Susceptibility locus for clinical and subclinical coronary artery disease at chromosome …

- oxfordjournals.org
TL Assimes, JW Knowles, A Basu, C Iribarren, … - Human Molecular Genetics, 2008 - Oxford Univ Press
A susceptibility locus for coronary artery disease (CAD) at chromosome 9p21 has
recently been reported, which may influence the age of onset of CAD. We sought
to replicate these findings among white subjects and to examine whether ...
Cited by 17 - Related articles - All 7 versions

Plasma leptin levels and coronary artery calcification in older adults

- endojournals.org
C Iribarren, G Husson, AS Go, JC Lo, JM Fair … - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc
Context: Leptin is associated with adiposity and insulin resistance and may play
a direct role in vascular calcification. It is unclear, however, whether leptin
is an independent predictor of atherosclerotic burden.
Cited by 10 - Related articles - BL Direct - All 4 versions

Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to …


MA Hlatky, E Ashley, T Quertermous, DB … - American Heart Journal, 2007 - Elsevier
We identified adults in a large integrated health care delivery system whose
initial clinical presentation of coronary disease was either an acute MI or
stable exertional angina. A total of 909 patients with acute MI, 466 ...
Cited by 10 - Related articles - All 5 versions

Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease

- pubget.com [PDF] 
TL Assimes, JW Knowles, JR Priest, A Basu, KA … - Human Genetics, 2008 - Springer
Abstract Recent human genetic studies suggest that alle- lic variants of
leukotriene pathway genes inXuence the risk of clinical and subclinical
atherosclerosis. We sequenced the promoter, exonic, and splice site regions ...
Cited by 9 - Related articles - All 5 versions

Recent trends in hospital utilization for acute myocardial infarction and coronary …


BK Nallamothu, J Young, HS Gurm, G Pickens, … - The American Journal of Cardiology, 2007 - Elsevier
Medical advances may be shifting patients with coronary artery disease away from
the hospital setting despite an aging United States population. We explored this
possibility using national inpatient data to estimate the number and ...
Cited by 9 - Related articles - All 2 versions

A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of …

- nih.gov
TL Assimes, JW Knowles, JR Priest, A Basu, A … - Atherosclerosis, 2008 - Elsevier
We resequenced ALOX15 and then genotyped a common promoter and a less common
novel coding SNP (T560M) in 1809 subjects with CAD and 1734 controls from Kaiser
Permanente including a subset of participants of the Coronary Artery Risk ...
Cited by 7 - Related articles - All 32 versions

Circulating chemokines accurately identify individuals with clinically significant …

- physiology.org
D Ardigo, TL Assimes, SP Fortmann, AS Go, M … - Physiological genomics, 2007 - Am Physiological Soc
Serum inflammatory markers correlate with outcome and response to therapy in
subjects with cardiovascular disease. However, current individual markers lack
specificity for the diagnosis of coronary artery disease (CAD). We ...
Cited by 6 - Related articles - BL Direct - All 5 versions

Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have …

- nursing2008.com
H Itakura, BE Sobel, D Boothroyd, LL Leung, … - American Heart Journal, 2007 - Elsevier
We compared plasma concentrations of fibrinogen, d-dimer, tissue-type
plasminogen activator, and plasminogen activator inhibitor-1 (PAI-1) between
patients whose first clinical manifestation of CAD was an AMI (n = 198) ...
Cited by 5 - Related articles - All 4 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google